Literature DB >> 18201914

Alteration of N-glycans related to articular cartilage deterioration after anterior cruciate ligament transection in rabbits.

T Matsuhashi1, N Iwasaki, H Nakagawa, M Hato, M Kurogochi, T Majima, A Minami, S-I Nishimura.   

Abstract

OBJECTIVE: Osteoarthritis (OA) is the most common of all joint diseases, but the molecular basis of its onset and progression is controversial. Several studies have shown that modifications of N-glycans contribute to pathogenesis. However, little attention has been paid to N-glycan modifications seen in articular cartilage. The goal of this study was to identify disease specific N-glycan expression profiles in degenerated cartilage in a rabbit OA model induced by anterior cruciate ligament transection (ACLT).
METHODS: Cartilage samples were harvested at 7, 10, 14, and 28 days after ACLT and assessed for cartilage degeneration and alteration in N-glycans. N-Glycans from cartilage were analyzed by high performance liquid chromatography and mass spectrometry.
RESULTS: Histological analysis showed that osteoarthritic changes in cartilage occurred 10 days after ACLT. Apparent alterations in the N-glycan peak pattern in cartilage samples were observed 7 days after ACLT, and overall N-glycan changes in OA reflected alterations in both sialylation and fucosylation. These changes apparently preceded histological changes in cartilage.
CONCLUSION: These results indicate that changes in the expression of N-glycans are correlated with OA in an animal model. Understanding mechanisms underlying changes in N-glycans seen in OA may be of therapeutic value in treating cartilage deterioration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18201914     DOI: 10.1016/j.joca.2007.11.004

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  6 in total

1.  Human osteoarthritic knee cartilage: fingerprinting of adhesion/growth-regulatory galectins in vitro and in situ indicates differential upregulation in severe degeneration.

Authors:  Stefan Toegel; Daniela Bieder; Sabine André; Klaus Kayser; Sonja M Walzer; Gerhard Hobusch; Reinhard Windhager; Hans-Joachim Gabius
Journal:  Histochem Cell Biol       Date:  2014-07-01       Impact factor: 4.304

2.  Mass spectrometry imaging spatially identifies complex-type N-glycans as putative cartilage degradation markers in human knee osteoarthritis tissue.

Authors:  Yea-Rin Lee; Matthew T Briggs; Clifford Young; Mark R Condina; Julia S Kuliwaba; Paul H Anderson; Peter Hoffmann
Journal:  Anal Bioanal Chem       Date:  2022-09-20       Impact factor: 4.478

3.  Phenotype-related differential alpha-2,6- or alpha-2,3-sialylation of glycoprotein N-glycans in human chondrocytes.

Authors:  S Toegel; M Pabst; S Q Wu; J Grass; M B Goldring; C Chiari; A Kolb; F Altmann; H Viernstein; F M Unger
Journal:  Osteoarthritis Cartilage       Date:  2009-09-22       Impact factor: 6.576

4.  Elevation of α-1,3 fucosylation promotes the binding ability of TNFR1 to TNF-α and contributes to osteoarthritic cartilage destruction and apoptosis.

Authors:  Hanjie Yu; Mingxiu Li; Xiaodong Wen; Jie Yang; Xiaojun Liang; Xia Li; Xiaojuan Bao; Jian Shu; Xiameng Ren; Wentian Chen; Zheng Li; Yi Li
Journal:  Arthritis Res Ther       Date:  2022-04-29       Impact factor: 5.606

5.  Therapeutic Effects of Intra-Articular Ultrapurified Low Endotoxin Alginate Administration on Experimental Osteoarthritis in Rabbits.

Authors:  Tatsuya Igarashi; Norimasa Iwasaki; Daisuke Kawamura; Yukinori Tsukuda; Yasuhiko Kasahara; Masahiro Todoh; Shigeru Tadano; Akio Minami
Journal:  Cartilage       Date:  2012-01       Impact factor: 4.634

6.  Glycophenotyping of osteoarthritic cartilage and chondrocytes by RT-qPCR, mass spectrometry, histochemistry with plant/human lectins and lectin localization with a glycoprotein.

Authors:  Stefan Toegel; Daniela Bieder; Sabine André; Friedrich Altmann; Sonja M Walzer; Herbert Kaltner; Jochen G Hofstaetter; Reinhard Windhager; Hans-Joachim Gabius
Journal:  Arthritis Res Ther       Date:  2013-10-04       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.